Identification of SARS-CoV-2 variants of concern in vaccine-breakthrough infections

J Infect Dev Ctries. 2022 Apr 30;16(4):580-582. doi: 10.3855/jidc.15458.

Authors

Baha Abdalhamid¹, Matthew Donahue², Ishrat Kamal-Ahmed², Kyle Strand², Elizabeth Mitchell³, Peter C Iwen³

Affiliations

¹ Nebraska Public Health Laboratory, University of Nebraska Medical Center, Omaha, NE, United States. babdalhamid@unmc.edu.
² Division of Public Health-Epidemiology and Informatics Unit, Nebraska Department of Health and Human Services, Lincoln, NE, United States.
³ Nebraska Public Health Laboratory, University of Nebraska Medical Center, Omaha, NE, United States.

PMID: 35544616
DOI: 10.3855/jidc.15458

No abstract available

Keywords: COVID-19; SARS-CoV-2; vaccine.

MeSH terms

COVID-19 Vaccines
COVID-19* / prevention & control
Communicable Diseases*
Humans
SARS-CoV-2 / genetics

Substances

COVID-19 Vaccines

Supplementary concepts

SARS-CoV-2 variants